MIAMI, April 11, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Firm”), a scientific stage biotechnology firm creating mobile therapies for life-threatening and power aging-related circumstances equivalent to…
Tag: